Clinical Trial Update: Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of pyridostigmine (Mestinon) on muscle strength in patients with Myasthenia Gravis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Mestinon (pyridostigmine bromide)

Snippet

Sponsor: University of Aarhus | Conditions: Myasthenia Gravis | Phase 4 | Status: UNKNOWN